These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 11563821)
21. Beta-amyloid precursor protein transgenic mice that harbor diffuse A beta deposits but do not form plaques show increased ischemic vulnerability: role of inflammation. Koistinaho M; Kettunen MI; Goldsteins G; Keinänen R; Salminen A; Ort M; Bures J; Liu D; Kauppinen RA; Higgins LS; Koistinaho J Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1610-5. PubMed ID: 11818564 [TBL] [Abstract][Full Text] [Related]
22. Do axonal defects in tau and amyloid precursor protein transgenic animals model axonopathy in Alzheimer's disease? Götz J; Ittner LM; Kins S J Neurochem; 2006 Aug; 98(4):993-1006. PubMed ID: 16787410 [TBL] [Abstract][Full Text] [Related]
23. Swedish amyloid precursor protein mutation increases cell cycle-related proteins in vitro and in vivo. Ahn KW; Joo Y; Choi Y; Kim M; Lee SH; Cha SH; Suh YH; Kim HS J Neurosci Res; 2008 Aug; 86(11):2476-87. PubMed ID: 18438935 [TBL] [Abstract][Full Text] [Related]
24. Noradrenaline deficiency in brain increases beta-amyloid plaque burden in an animal model of Alzheimer's disease. Kalinin S; Gavrilyuk V; Polak PE; Vasser R; Zhao J; Heneka MT; Feinstein DL Neurobiol Aging; 2007 Aug; 28(8):1206-14. PubMed ID: 16837104 [TBL] [Abstract][Full Text] [Related]
25. Does oxybutynin alter plaques, amyloid beta peptides and behavior in a mouse model of Alzheimer's disease? Klausner AP; Sharma S; Fletcher S; Neff P; Yang SK; Son H; Tuttle JB; Steers WD J Urol; 2008 Mar; 179(3):1173-7. PubMed ID: 18206173 [TBL] [Abstract][Full Text] [Related]
26. Peripheral and central biodistribution of (111)In-labeled anti-beta-amyloid autoantibodies in a transgenic mouse model of Alzheimer's disease. Bacher M; Depboylu C; Du Y; Noelker C; Oertel WH; Behr T; Henriksen G; Behe M; Dodel R Neurosci Lett; 2009 Jan; 449(3):240-5. PubMed ID: 18786612 [TBL] [Abstract][Full Text] [Related]
27. Time course of the development of Alzheimer-like pathology in the doubly transgenic PS1+APP mouse. Gordon MN; Holcomb LA; Jantzen PT; DiCarlo G; Wilcock D; Boyett KW; Connor K; Melachrino J; O'Callaghan JP; Morgan D Exp Neurol; 2002 Feb; 173(2):183-95. PubMed ID: 11822882 [TBL] [Abstract][Full Text] [Related]
28. Stereological analysis of microvascular parameters in a double transgenic model of Alzheimer's disease. Lee GD; Aruna JH; Barrett PM; Lei DL; Ingram DK; Mouton PR Brain Res Bull; 2005 Apr; 65(4):317-22. PubMed ID: 15811597 [TBL] [Abstract][Full Text] [Related]
29. A highly insoluble state of Abeta similar to that of Alzheimer's disease brain is found in Arctic APP transgenic mice. Philipson O; Hammarström P; Nilsson KP; Portelius E; Olofsson T; Ingelsson M; Hyman BT; Blennow K; Lannfelt L; Kalimo H; Nilsson LN Neurobiol Aging; 2009 Sep; 30(9):1393-405. PubMed ID: 18192084 [TBL] [Abstract][Full Text] [Related]
39. A promising animal model of Alzheimer's disease. Tanzi RE N Engl J Med; 1995 Jun; 332(22):1512-3. PubMed ID: 7739692 [No Abstract] [Full Text] [Related]
40. Human umbilical cord blood effect on sod mice (amyotrophic lateral sclerosis). Ende N; Weinstein F; Chen R; Ende M Life Sci; 2000 May; 67(1):53-9. PubMed ID: 10896029 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]